Global Antacids Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global antacids industry growth, size, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Antacids, available without a prescription, are medicinal substances designed to counteract surplus stomach acid. They comprise calcium carbonate, aluminum hydroxide, magnesium hydroxide, or a blend of these components. Their mechanism involves interacting with stomach acid, thereby diminishing its acidity and providing relief from discomfort. Antacids come in different forms such as tablets, liquids, and chewable variants. They are widely utilized for rapid alleviation of conditions like heartburn, indigestion, and sour stomach.
Global Antacids Market Trends and Drivers:
The prevalence of conditions like gastroesophageal reflux disease (GERD), acid reflux, heartburn, indigestion, peptic ulcers, and gastritis is on the rise. This surge is significantly driven by the increasing elderly population, who are more susceptible to developing these ailments. Furthermore, changing lifestyles characterized by irregular dietary habits, disrupted sleep patterns, and sedentary behaviors contribute to this trend. The demand for antacids globally is fueled not only by these factors but also by heightened awareness of digestive health and easier access to over-the-counter (OTC) medications. The convenience of obtaining antacids plays a crucial role in this market growth, facilitated by the growing culture of coffee consumption and social drinking occasions that may lead to digestive discomfort. Additionally, the easy availability of antacids both online and offline, including in pharmacies and convenience stores, further supports the expansion of the market.
Global Antacids Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
The report segmented the market on the basis of region, drug class, formulation type and distribution channel.
Breakup by Drug Class:
Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
Breakup by Formulation Type:
Tablet
Liquid
Powder
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us: IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Comments